Castleark Management’s Precigen PGEN Stock Holding History

Castleark Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-27,420	Closed	-$864K	–	410
2015 Q3	$864K	Buy	+27,420	New	+$1.34M	0.03%	294

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Castleark Management's PGEN Position: Q4 2015 in Review

Castleark Management sold out of Precigen (PGEN) in Q4 2015, closing a stake of 27,420 shares — an estimated $864K sold.

Castleark Management first reported a position in PGEN in Q3 2015 and held it in 1 quarter. The position peaked at $864K in Q3 2015. 180 funds tracked by Wall St. Rank hold PGEN as of Q4 2015.

Castleark Management reported no remaining Precigen position as of Q4 2015 after selling out during the quarter.
Castleark Management sold 27,420 Precigen shares in Q4 2015, an estimated $864K.
Castleark Management first reported a position in Precigen in Q3 2015 and held it in 1 quarter.
Castleark Management's Precigen position peaked at $864K in Q3 2015.
180 funds tracked by Wall St. Rank held Precigen as of Q4 2015.

Based on Castleark Management's 13F filing for Q4 2015, filed 17 Feb 2016.